+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Fulvestrant"

ER positive, HER2 negative Breast Cancer - Pipeline Insight, 2024 - Product Thumbnail Image

ER positive, HER2 negative Breast Cancer - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 40 Pages
  • Global
From
Metastatic HR+/HER2 - Breast Cancer - Market Insights, Epidemiology, and Market Forecast-2032 - Product Thumbnail Image

Metastatic HR+/HER2 - Breast Cancer - Market Insights, Epidemiology, and Market Forecast-2032

  • Report
  • November 2023
  • 353 Pages
  • Global
From
Global SERD Therapeutics Market: Focus on Product, Therapy, Country Data (14 Countries), and Competitive Landscape - Analysis and Forecast, 2019-2030 - Product Thumbnail Image

Global SERD Therapeutics Market: Focus on Product, Therapy, Country Data (14 Countries), and Competitive Landscape - Analysis and Forecast, 2019-2030

  • Report
  • March 2021
  • 207 Pages
  • Global
From
US Breast Cancer Drug Market, Drug Price, Dosage & Clinical Trials Insight 2026 - Product Thumbnail Image

US Breast Cancer Drug Market, Drug Price, Dosage & Clinical Trials Insight 2026

  • Report
  • January 2021
  • 900 Pages
  • United States
From
ESR1 Mutated Metastatic Breast Cancer - Market Insight, Epidemiology And Market Forecast - 2032 - Product Thumbnail Image

ESR1 Mutated Metastatic Breast Cancer - Market Insight, Epidemiology And Market Forecast - 2032

  • Report
  • April 2023
  • 180 Pages
  • Global
From
United States KISQALI Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

United States KISQALI Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • January 2023
  • 30 Pages
  • United States
From
IBRANCE Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

IBRANCE Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • January 2023
  • 30 Pages
  • Global
From
United States VERZENIO Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

United States VERZENIO Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • January 2023
  • 30 Pages
  • United States
From
FASLODEX Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

FASLODEX Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • January 2023
  • 30 Pages
  • Global
From
United States PIQRAY Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

United States PIQRAY Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • January 2023
  • 30 Pages
  • United States
From
ER+/HER2 -ve Breast Cancer - Pipeline Insight, 2021 - Product Thumbnail Image

ER+/HER2 -ve Breast Cancer - Pipeline Insight, 2021

  • Clinical Trials
  • February 2021
  • 60 Pages
  • Global
From
Breast Cancer Treatment Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2022 To 2030 - Product Thumbnail Image

Breast Cancer Treatment Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2022 To 2030

  • Report
  • August 2022
  • 119 Pages
  • Global
From
Fulvestrant Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application - Product Thumbnail Image

Fulvestrant Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

  • Report
  • March 2024
  • 85 Pages
  • Global
From
Breast Cancer Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Product Type - Product Thumbnail Image

Breast Cancer Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Product Type

  • Report
  • January 2024
  • 93 Pages
  • Global
From
Drug and Therapy Development for Triple Negative Breast Cancer. Edition No. 1 - Product Thumbnail Image

Drug and Therapy Development for Triple Negative Breast Cancer. Edition No. 1

  • Book
  • July 2023
  • 320 Pages
  • 15 Results (Page 1 of 1)
Loading Indicator

Fulvestrant is a type of breast cancer drug used to treat hormone receptor-positive metastatic breast cancer. It is a type of hormone therapy, which works by blocking the effects of the hormone estrogen on cancer cells. Fulvestrant is administered as an intramuscular injection, and is typically used in combination with other treatments such as chemotherapy. It is used in postmenopausal women who have already been treated with other hormone therapies, such as tamoxifen. Fulvestrant is a relatively new drug, and is still being studied in clinical trials. It has been found to be effective in treating certain types of breast cancer, and is generally well-tolerated by patients. It is also being studied for its potential to be used in combination with other treatments, such as immunotherapy. Some companies in the Fulvestrant market include AstraZeneca, Pfizer, Novartis, and Eli Lilly. Show Less Read more